Target intelligence / Profile preview

Human metapneumovirus hemagglutinin-neuraminidase protein (hMPV HN)

Target
hMPV HN
Molecular classification
Viral surface glycoprotein, Enzyme
01

Overview

Human metapneumovirus (hMPV) is a significant viral pathogen responsible for a high burden of respiratory disease, particularly in pediatric and geriatric populations (Van den Hoogen et al., 2001). A defining characteristic of hMPV, which distinguishes it from many other paramyxoviruses, is that it does not possess a hemagglutinin-neuraminidase (HN) protein (ViralZone, SIB). The viral surface is instead characterized by the Fusion (F) protein, the Attachment (G) protein, and the Small Hydrophobic (SH) protein (Schildgen et al., 2011). The F protein is essential for viral entry and is the primary target for neutralizing antibodies, whereas the G protein facilitates initial cell surface binding but lacks the neuraminidase and hemagglutinating activities typical of HN proteins (Bi et al., 2007). Consequently, the Human metapneumovirus hemagglutinin-neuraminidase protein is a biologically non-existent entity for this virus, and therapeutic development for hMPV focuses on the F protein rather than an HN-like target.

Other names
hMPV HN proteinHemagglutinin-neuraminidase of hMPV
02

Mechanism of action

Not applicable; this protein is not encoded by the Human metapneumovirus genome.

03

Biological functions

Viral attachmentNeuraminidase activityViral entry
04

Disease associations

InfectionRespiratory tract infection
05

Safety considerations

Target non-existence in the specified pathogenMisidentification of therapeutic focus

Beyond the preview

Go deeper on Human metapneumovirus hemagglutinin-neuraminidase protein (hMPV HN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human metapneumovirus hemagglutinin-neuraminidase protein (hMPV HN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call